World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
79
Citations
40309
World Ranking
17349
National Ranking
238

Overview

Guillermo Sanz is affiliated with the Hospital Universitari i Politècnic La Fe in Spain. Their research primarily focuses on hematology, genetics, and oncology, contributing extensively to the understanding and treatment of blood disorders.

Their recent scholarly output includes significant papers such as "Molecular International Prognostic Scoring System for Myelodysplastic Syndromes" published in 2022 in NEJM Evidence, "Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes" from 2020 in Nature Medicine, and "Classification and Personalized Prognostic Assessment on the Basis of Clinical and Genomic Features in Myelodysplastic Syndromes" published in 2021 in the Journal of Clinical Oncology. Other papers include "Myelodysplastic syndromes: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†" (2020, Annals of Oncology) and "Omidubicel vs standard myeloablative umbilical cord blood transplantation: results of a phase 3 randomized study" (2021, Blood).

Their research contributions are distributed across a range of specialized topics including:

  • Acute Myeloid Leukemia Research
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Hematopoietic Stem Cell Transplantation
  • Cancer Genomics and Diagnostics
  • Acute Lymphoblastic Leukemia research
  • Chronic Myeloid Leukemia Treatments
  • Polyomavirus and related diseases

The main fields of study cover Medicine with a significant focus on subfields such as:

  • Hematology
  • Genetics
  • Oncology
  • Molecular Biology
  • Cancer Research

Guillermo Sanz collaborates frequently with other researchers in the field, notably with Pierre Fenaux, Valeria Santini, Uwe Platzbecker, Matteo Giovanni Della Porta, and Ulrich Germing.

Their work is regularly published in prominent scientific venues including:

  • Blood
  • Leukemia Research
  • Transplantation and Cellular Therapy
  • HemaSphere
  • Clinical Lymphoma Myeloma & Leukemia

Best Publications

  • International Scoring System for Evaluating Prognosis in Myelodysplastic Syndromes

    Peter Greenberg;Christopher Cox;Michelle M. LeBeau;Pierre Fenaux

  • Revised International Prognostic Scoring System for Myelodysplastic Syndromes

    Peter L. Greenberg;Heinz Tuechler;Julie Schanz;Guillermo Sanz

  • Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study.

    Pierre Fenaux;Ghulam J. Mufti;Eva Hellstrom-Lindberg;Valeria Santini

  • Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia

    Bruce D. Cheson;Peter L. Greenberg;John M. Bennett;Bob Lowenberg

  • Transplants of Umbilical-Cord Blood or Bone Marrow from Unrelated Donors in Adults with Acute Leukemia

    Vanderson Rocha;Myriam Labopin;Guillermo Sanz;William Arcese

  • Azacitidine Prolongs Overall Survival Compared With Conventional Care Regimens in Elderly Patients With Low Bone Marrow Blast Count Acute Myeloid Leukemia

    Pierre Fenaux;Ghulam J. Mufti;Eva Hellström-Lindberg;Valeria Santini

  • Report of an international working group to standardize response criteria for myelodysplastic syndromes

    B. D. Cheson;J. M. Bennett;Hagop M Kantarjian;A. Pinto

  • Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet

    Luca Malcovati;Eva Hellström-Lindberg;David Bowen;Lionel Adès

  • Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis

    Mary Eapen;Vanderson Rocha;Guillermo Sanz;Andromachi Scaradavou

  • Two regression models and a scoring system for predicting survival and planning treatment in myelodysplastic syndromes: a multivariate analysis of prognostic factors in 370 patients.

    GF Sanz;MA Sanz;T Vallespi;MC Canizo

  • Proposal for a new risk model in myelodysplastic syndrome that accounts for events not considered in the original International Prognostic Scoring System.

    Hagop Kantarjian;Susan O'Brien;Farhad Ravandi;Jorge Cortes

  • A randomized phase 3 study of lenalidomide versus placebo in RBC transfusion-dependent patients with Low-/Intermediate-1-risk myelodysplastic syndromes with del5q

    Pierre Fenaux;Aristoteles Giagounidis;Dominik Selleslag;Odile Beyne-Rauzy

  • Factors associated with outcomes of unrelated cord blood transplant: Guidelines for donor choice

    Eliane Gluckman;Vanderson Rocha;William Arcese;Gérard Michel

  • Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes

    Elsa Bernard;Yasuhito Nannya;Robert P. Hasserjian;Sean M. Devlin

  • Diagnosis and classification of myelodysplastic syndrome: International Working Group on Morphology of myelodysplastic syndrome (IWGM-MDS) consensus proposals for the definition and enumeration of myeloblasts and ring sideroblasts

    Ghulam J. Mufti;John M. Bennett;Jean Goasguen;Barbara J. Bain

  • Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel

    Theo De Witte;David Bowen;Marie Robin;Luca Malcovati

  • Incidence, characterization and prognostic significance of chromosomal abnormalities in 640 patients with primary myelodysplastic syndromes. Grupo Cooperativo Español de Citogenética Hematológica.

    F Solé;B Espinet;G F Sanz;J Cervera

  • Development and validation of a prognostic scoring system for patients with chronic myelomonocytic leukemia

    Esperanza Such;Ulrich Germing;Luca Malcovati;José Cervera

  • Standardized, unrelated donor cord blood transplantation in adults with hematologic malignancies.

    Guillermo F. Sanz;Silvana Saavedra;Dolores Planelles;Leonor Senent

  • Cytogenetic risk stratification in chronic myelomonocytic leukemia

    Esperanza Such;José Cervera;Dolors Costa;Francesc Solé

Frequent Co-Authors

Miguel A. Sanz
Miguel A. Sanz University of Valencia
Pierre Fenaux
Pierre Fenaux Université Paris Cité
Ulrich Germing
Ulrich Germing Heinrich Heine University Düsseldorf
Eva Hellström-Lindberg
Eva Hellström-Lindberg Karolinska University Hospital
Eliane Gluckman
Eliane Gluckman Université Paris Cité
Vanderson Rocha
Vanderson Rocha Universidade de São Paulo
Francesc Solé
Francesc Solé Autonomous University of Barcelona
Ghulam J. Mufti
Ghulam J. Mufti King's College London
David Bowen
David Bowen Royal Prince Alfred Hospital
Peter L. Greenberg
Peter L. Greenberg Stanford University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative health-related degrees and career pathways can open new doors for students interested in the medical field. Many choose online programs for their flexibility and quick turnaround. For example, if you have a non-nursing bachelor’s degree, you can consider non nursing bachelor's to msn online programs, which let you enter nursing at the master’s level with fewer prerequisites.

Some students look for the easiest rn program to get into in order to launch their careers sooner, focusing on schools with higher acceptance rates and less competitive admissions criteria. For those interested in administrative roles, there are also reputable online medical billing and coding schools that accept fafsa, making education more accessible through financial aid.

If standardized exams are a barrier, you might benefit from schools where do you have to take a teas test for lpn is not required, helping you start your journey with less stress. These pathways offer diverse opportunities in healthcare for students with varying backgrounds and goals.

Best Scientists Citing Guillermo Sanz

Trending Scientists